Skip to content

Clinical trials

Phase 2 Retinal Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Diseases Phase: Phase 2 Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20073
20101
20121
20151
20191
20205
20213
20221
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated7
Active, not recruiting2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gyroscope Therapeutics Limited3
Neurotech Pharmaceuticals3
Gemini Therapeutics, Inc.2
Laboratoires Thea2
National Eye Institute (NEI)2
Unity Biotechnology, Inc.2
Adverum Biotechnologies, Inc.1
Alkahest, Inc.1
Allergan1
Eye Center of Northern Colorado, P.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Diseases25
Eye Diseases13
Retinal Degeneration11
Macular Degeneration7
Geographic Atrophy5
Macular Edema5
Retinitis Pigmentosa5
Anetoderma3
Diabetes Mellitus3
Diabetic Retinopathy3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.